Evaluation of the Effect of Flaxseed Lignan on Blood Cholesterol - A randomized, double-blind, parallel-group study

Not Applicable

• Conditions: healthy person

• Registration Number: JPRN-UMIN000046202
• Lead Sponsor: Clinical Creative Co., Ltd.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-01-27
• Study Completion: 2022-06-18
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Not provided

Exclusion Criteria

1) Those who show allergic reactions to flaxseed. 2) Those who are in the habit of consuming large amounts of flaxseed and the Study Food Ingredients (SDG). 3) Those who are pregnant or intend to become pregnant during the study period, or those who are lactating. 4) Those who have participated in other clinical studies within 3 months of consent and those who plan to participate in other clinical studies during the study period. 5) Subjects whose anthropometric, physical, or clinical values in the preliminary examination are significantly out of the reference range. 6) Those who regularly use medicines, food for specified health use, functional food, or health food that may affect the evaluation items. 7) Those who have a history of drug dependence or alcohol dependence, or a current medical history. 8) Those who are undergoing treatment for a disease, or have a history of a serious disease that required medication. 9) Patients with serious diseases such as diabetes, hepatic disease, renal disease, or cardiac disease, or those with a history of such diseases. 10) Others who are judged by the principal investigator or sub-investigator to be inappropriate for the study (the study may increase the risk to the research subjects or may not provide sufficient data).

Study & Design

• Study Type: Interventional
• Study Design: Not specified